Canada’s declining competitiveness in clinical research.
Provide financial support to the provinces interested in enhancing their capabilities to attract international clinical studies.
Implement initiatives aimed at standardizing Canadian skills in terms of clinical research.
Allow the NRCC-IRAP program to finance the clinical phases of product development by Canadian SMEs.
Increased number of clinical studies sponsored by the Canadian industry.
Increased number of clinical research jobs in Canada, particularly in SMEs (biotech, medtech, CRO).
Overall increase in the ability and effectiveness of clinical studies in Canada.